Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy (SABAL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Karin Dam Petersen, Aalborg University
ClinicalTrials.gov Identifier:
NCT01486498
First received: December 3, 2011
Last updated: December 5, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)